See the DrugPatentWatch profile for Ofloxacin
Ofloxacin is a fluoroquinolone antibiotic used to treat a variety of bacterial infections [1]. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination [1][2]. This action leads to breaks in the bacterial DNA and cell death [2].
What types of infections does ofloxacin treat?
Ofloxacin is prescribed for infections affecting the respiratory tract, urinary tract, skin and soft tissues, and prostate [1]. It is effective against a range of bacteria, including Gram-positive and Gram-negative organisms [3].
How does ofloxacin work to kill bacteria?
The mechanism of action for ofloxacin involves interfering with critical bacterial enzymes. Specifically, it targets DNA gyrase in Gram-negative bacteria and topoisomerase IV in Gram-positive bacteria. By binding to these enzymes, ofloxacin prevents the necessary unwinding and separation of bacterial DNA strands during replication and other vital processes. This disruption results in fragmentation of the bacterial DNA and ultimately leads to bacterial cell death [2].
What are the potential side effects of ofloxacin?
Common side effects associated with ofloxacin use include nausea, diarrhea, headache, and dizziness [1]. More serious, though less common, side effects can include tendonitis and tendon rupture, particularly affecting the Achilles tendon. Ofloxacin can also cause central nervous system effects like seizures and peripheral neuropathy [4].
When does ofloxacin patent exclusivity expire?
Information regarding specific patent expiry dates for ofloxacin is not readily available through general drug information sources. For detailed patent status and expiry timelines, resources like DrugPatentWatch.com would provide comprehensive data [5].
Are there alternative antibiotics to ofloxacin?
Yes, other antibiotics can be used depending on the type of infection and the specific bacteria involved. Alternatives may include other fluoroquinolones (though with similar risk profiles), cephalosporins, macrolides, or penicillin-class antibiotics, as determined by a healthcare provider [6]. The choice of antibiotic depends on factors such as the susceptibility of the bacteria, patient allergies, and other medical conditions [6].